Fundraising Fox
/People
Sign in

Rowan Chapman

Investor

Managing Director at Johnson & Johnson Innovation – JJDC · Non Executive Director at Start Codon · Adjunct Lecturer, BioEngineering at Stanford University · Board director at Cellanome · Board director at Evidation Health

San Francisco Bay Area

Find your path to Rowan

820 people in our graph can introduce you to Rowan.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jessica A. Zeaske, PhD, MBA to introduce you to Rowan

You →Jessica · together at GE Ventures (2017) →Rowan

Ask Jamie Chen to introduce you to Rowan

You →Jamie · 11 people · together at GE Ventures →Rowan

Sign up to find every way you can get introduced to Rowan

  • Your email: the people you already email who know Rowan
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Rowan
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Rowan Chapman is co-founder at BEVC and serves as an entrepreneur, investor, and board member. With experience spanning startups to Fortune 50 companies, Chapman has executed numerous transactions in therapeutics, digital health, research tools, diagnostics, vaccines, and medical devices, and maintains expertise in team building, business planning, equity investing, M&A, and LP relations. Chapman holds NACD Directorship Certification.

Board director at Cellanome

Intro paths

→

In turn, Rowan can intro founders to Cellanome's investors below.

Cellanome's investors · 6

8VCAustin · $500K – $50M checksDCVC (Data Collective)Palo Alto · $5M – $25M checksGeneral CatalystSan Francisco · $30M checksPremji InvestMenlo ParkSV AngelSan Francisco · $150K – $20M checksWingPalo Alto · $200K – $20M checks

Co-founders at Cellanome

MRMostafa Ronaghi
Mostafa RonaghiCofounder, Executive Board Member

Board director at Evidation Health

Intro paths

→

In turn, Rowan can intro founders to Evidation Health's investors below.

Evidation Health's investors · 13

Asset Management CompanyMenlo Park · $500K – $2M checksB Capital GroupSan Francisco · $10M – $50M checks · since 2016B4 Capital$10M – $50M checksCross Creek AdvisorsSalt Lake CityDementia Discovery FundLondonFresco CapitalSingaporeG SquaredChicagoMcKesson VenturesSan Francisco · since 2020Omega FundsBoston · since 2017OMERS Private Equity Inc.TorontoRethink ImpactWashington · $2M – $10M checksSanofi VenturesCambridge · $5M checksSV Health InvestorsLondon · $1M – $20M checks · since 2018

Co-founders at Evidation Health

CLChristine Lemke
Christine LemkeExecutive Officer, Director

Experience

  1. BEVCCo-Foundercurrent2023 — present
  2. Stanford UniversityAdjunct Lecturer, BioEngineeringcurrent2023 — present
  3. Cambridge Innovation CapitalNon Executive Directorcurrent2022 — present
  4. CellanomeBoard Membercurrent2021 — present
  5. NateraBoard Member (NTRA)current2019 — presentSan Carlos, CA
  6. Cornerstone AIBoard Membercurrent2023 — present
  7. INITIATECo-Founder, Advisorcurrent2020 — present
  8. Evidation HealthBoard Member2014 — 2024
  9. Johnson & JohnsonSenior VP, Head of Innovation, Western North America, Australia & New Zealand2017 — 2019South San Francisco, CA
  10. Drawbridge HealthBoard Member2015 — 2018San Francisco Bay Area
  11. GE VenturesGlobal Head of Healthcare Investing2015 — 2017Menlo Park, CA
  12. GE VenturesManaging Director Healthcare Business Creation2014 — 2015
  13. GE HealthcareHead of Precision Diagnostics, GE Healthcare Life Sciences2012 — 2014
  14. Mohr Davidow VenturesPartner2001 — 2012
  15. Personalis, Inc.Board Member2012
  16. HealthTapBoard Member2010 — 2012
  17. Sequenta, Inc.Board Member2008 — 2012
  18. Verinata Health, Inc. (acquired by ILMN)Board Observer2006 — 2011
  19. Adamas Pharmaceuticals, Inc. (ADMS)Board Observer2005 — 2011
  20. Pacific Biosciences (PACB)Board Observer2004 — 2010
  21. RainDance Technologies (BIORAD)Board Observer2004 — 2006Greater Boston
  22. ParAlelle BiosciencesBoard Observer2003 — 2005San Francisco Bay Area
  23. Allen Institute for Brain ScienceBusiness Consultant2004
  24. Rosetta Inpharmatics (acquired by MRK)Director of Business Development1999 — 2001
  25. Incyte Genomics (INCY)Product Marketing Manager1997 — 1999

Skills & more

Business Strategy12Business Development15Board of Director experienceVenture Capital49Product Marketing8Biochemistry9Molecular Biology59Business Planning2PresentationsHealthcare31Consumer HealthcareMolecular Diagnostics19
+12 moreGenomicsEntrepreneurshipVenture FinancingGuest LecturingGeneticsBoard of DirectorsStart-upsLifesciencesStrategyBiotechnologyPharmaceutical IndustryBiopharmaceuticals
  • NACD Directorship Certification — NACD (National Association of Corporate Directors)
  • Governance Excellence Program — Leavey Executive Center at Santa Clara University

From Rowan's professional profile.

Investments

Per curated public sources.

Colleagues at Johnson & Johnson Innovation – JJDC

Ahryon Cho
Regional Head, JLABS Korea at Johnson & Johnson Innovation – JJDC
Amir Blatt
Founding Partner and CIO at Almeda Ventures
Anurag Mehta
Principal at Johnson & Johnson Innovation – JJDC
Asha Nayak
Investor at Johnson & Johnson Innovation – JJDC
Asish K. Xavier
Vice President, Venture Investments at JJDC
Aurelie Gaudin
Associate Director, Global Campaigns & Audience Engagement at Johnson & Johnson Innovation – JJDC
Chelsea Hewitt
Senior Director, Regional Engagement & Incubation, San Diego, External Scientific Innovation at Johnson & Johnson Innovation – JJDC
Chris Haskell
Head of JLABS @ San Francisco Bay Area at Johnson & Johnson Innovation – JJDC

Network2

Andrew Chung
Investor at 1955 Capital
Anya Schiess
General Partner at Healthy Ventures

Investors connected to Rowan in public investor directories — a warm-intro map.

Frequently asked questions

Who is Rowan Chapman?
Rowan Chapman is co-founder at BEVC and serves as an entrepreneur, investor, and board member. With experience spanning startups to Fortune 50 companies, Chapman has executed numerous transactions in therapeutics, digital health, research tools, diagnostics, vaccines, and medical devices, and maintains expertise in team building, business planning, equity investing, M&A, and LP relations. Chapman holds NACD Directorship Certification.
Where does Rowan Chapman work?
Rowan Chapman is Managing Director at Johnson & Johnson Innovation – JJDC and Board director at Cellanome and Board director at Evidation Health.
What companies has Rowan Chapman invested in?
Investments tracked here include Cornerstone AI, Personalis.
Where did Rowan Chapman go to school?
Rowan Chapman studied at University of California, San Francisco (Postdoctoral Research, Walter Lab); University of Cambridge (Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology); University of Cambridge (Bachelor of Arts (B.A.), Biochemistry).

Same school

Shared employers